Results 181 to 190 of about 145,799,037 (198)

Prevalence of Monoclonal Gammopathy of Undetermined Significance: Study of 52,802 Persons in Nagasaki City, Japan

Mayo Clinic Proceedings, 2007
Masako Iwanaga
exaly  

Fracture Risk in Monoclonal Gammopathy of Undetermined Significance

Journal of Bone and Mineral Research, 2004
Sundeep Khosla, S Vincent Rajkumar
exaly  

Monoclonal Gammopathy of Undetermined Significance and Smoldering Multiple Myeloma

Hematology/Oncology Clinics of North America, 2014
S Vincent Rajkumar, , Maria-Victoria Mateos   +2 more
exaly  

Monoclonal gammopathy of undetermined significance (MGUS) consistently precedes multiple myeloma: a prospective study

Blood, 2009
Shaji Kumar, Ola Landgren, Ruth Pfeiffer   +2 more
exaly  

A Long-Term Study of Prognosis in Monoclonal Gammopathy of Undetermined Significance

New England Journal of Medicine, 2002
Dirk Larson, S Vincent Rajkumar, Terry Therneau   +2 more
exaly  

Monoclonal gammopathies of undetermined significance.

Seminars in hematology, 1989
R A, Kyle, J A, Lust
openaire   +1 more source

Prevalence and risk of progression of light-chain monoclonal gammopathy of undetermined significance: a retrospective population-based cohort study

Lancet, The, 2010
Shaji Kumar, Angela Dispenzieri, S Vincent Rajkumar   +2 more
exaly  

Leukocytoclastic vasculitis associated with immunoglobulin A lambda monoclonal gammopathy of undetermined significance: A case report and review of previously reported cases

Journal of Dermatology, 2018
Hiroshi Umemura
exaly  

The risk of venous thromboembolic disease in patients with monoclonal gammopathy of undetermined significance

Annals of Oncology, 2004
exaly  

Prevention Is the Best Treatment: The Case for Understanding the Transition from Monoclonal Gammopathy of Undetermined Significance to Myeloma

International Journal of Molecular Sciences, 2018
Ali Ma, Fenghuang Zhan, Melissa L Bates   +2 more
exaly